Open Orphan starts trials on nasal spray Covid-19 vaccines

Trials have begun on next-generation vaccine, says Cathal Friel, executive chairman of Irish pharma digital services firm

24th January, 2021
Open Orphan starts trials on nasal spray Covid-19 vaccines
Cathal Friel of Open Orphan: ‘It is quite controversial, but it will be done under laboratory conditions.’ Picture: Fergal Phillips

Open Orphan has started trials on the next generation of Covid-19 vaccines, according to Cathal Friel, its founder.

The executive chairman and co-founder of the Irish pharmaceutical services company said it had begun phase one trials on a new Covid-19 nasal spray vaccine from US company Codagenix.

The Covi-Vac vaccine comes as a single dose nasal delivery spray and the clinical trial is being conducted by a subsidiary of Open Orphan’s in London called Hvivo....

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

New Covid-19 condition adds to worries for expectant mothers

Health Danielle Barron 2 days ago

Potential use of rapid antigen tests in workplaces and schools to be assessed

‘The next few weeks will give us hope if we can hang in there’

Health Danielle Barron 1 week ago